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Abstract
The conjunctiva is a moist mucosal membrane that is constantly exposed to an array of potential pathogens and triggers of
inflammation. The NACHT, leucine rich repeat (LRR), and pyrin domain-containing protein 3 (NLRP3) is a Nod-like receptor
that can sense pathogens or other triggers, and is highly expressed in wet mucosal membranes. NLRP3 is a member of the
multi-protein complex termed the NLRP3 inflammasome that activates the caspase 1 pathway, inducing the secretion of
biologically active IL-1b, a major initiator and promoter of inflammation. The purpose of this study was to: (1) determine
whether NLRP3 is expressed in the conjunctiva and (2) determine whether goblet cells specifically contribute to innate
mediated inflammation via secretion of IL-1b. We report that the receptors known to be involved in the priming and
activation of the NLRP3 inflammasome, the purinergic receptors P2X4 and P2X7 and the bacterial Toll-like receptor 2 are
present and functional in conjunctival goblet cells. Toxin-containing Staphylococcus aureus (S. aureus), which activates the
NLRP3 inflammasome, increased the expression of the inflammasome proteins NLRP3, ASC and pro- and mature caspase 1
in conjunctival goblet cells. The biologically active form of IL-1b was detected in goblet cell culture supernatants in response
to S. aureus, which was reduced when the cells were treated with the caspase 1 inhibitor Z-YVAD. We conclude that the
NLRP3 inflammasome components are present in conjunctival goblet cells. The NRLP3 inflammasome appears to be
activated in conjunctival goblet cells by toxin-containing S. aureus via the caspase 1 pathway to secrete mature IL1-b. Thus
goblet cells contribute to the innate immune response in the conjunctiva by activation of the NLRP3 inflammasome.
Citation: McGilligan VE, Gregory-Ksander MS, Li D, Moore JE, Hodges RR, et al. (2013) Staphylococcus aureus Activates the NLRP3 Inflammasome in Human and
Rat Conjunctival Goblet Cells. PLoS ONE 8(9): e74010. doi:10.1371/journal.pone.0074010
Editor: Suzanne Fleiszig, UC Berkeley, United States of America
Received April 11, 2013; Accepted July 25, 2013; Published September 10, 2013
Copyright:  2013 McGilligan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the United States Department of Defense Grant: FY08 W91XWH-09-2-0091, National Eye Institute R01EY 017381 and the
Parkinson’s Disease Society UK. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Competing Interests: The authors have declared that no competeing interests exist.
* E-mail: darlene.dartt@schepens.harvard.edu
. These authors contributed equally to this work.
Introduction
NOD Like Receptors (NLRs) have in recent years been
evidenced to be guardians of the body. They are intracellular
microbial and non-microbial sensors and include three main
proteins; NLRP1, NLRP3 and NLRC4. [1] Each of which are
known to form inflamamasomes, differing mainly in their
activation stimuli. The assembly and activation of an elaborate
multi-protein complex: nucleotide-binding oligomerization do-
main (NACHT), leucine rich repeat (LRR) domain, and pyrin
domain-containing protein 3 (NLRP3) inflammasome is respon-
sible for the recruitment of caspase 1 that processes IL-1b into a
mature and biologically active form. [1] The NLRP3 inflamma-
some consists of the NLRP3 protein, which senses intracellular
triggers resulting in oligomerization [2] that subsequently interacts
with ASC (apoptosis-associated speck-like protein) through homo-
typic interactions of the pyrin domain. [1] ASC then interacts with
pro caspase 1 resulting in cleavage and activation of caspase 1,
which in turn cleaves pro IL-1b to its active form. [1,3,4].
NLRP3 is activated by a plethora of stimuli such as endogenous
molecules including urate crystals, adenosine trisphosphate (ATP),
and particulate matter such as silica and asbestos. [5–7] Bacterial
stimuli such as Staphylococcus aureus (S. aureus), bacterial pore-
forming toxins, bacterial RNA, and bacterial cell wall components
lipopolysaccharide (LPS), lipoteichoic acid (LTA) and muramyl
dipeptide (MDP) also activate NLRP3. [6,8–10] The mechanism
of activation is not yet fully understood, but the processing of IL-
1b via the inflammasome has been demonstrated to involve two
pathways. [11] First, transcription of the pro form of IL-1b is
initiated by activation of the Toll-like receptor (TLR) induced
NFkB pathway. IL-1b is then cleaved to produce the biologically
active and secreted form by the activation of the caspase 1
pathway via inflammasome activation. The purinergic receptors
P2X4 and P2X7 have been shown to be involved in inflamma-
some activation, initiated by Danger Associated Molecular
Patterns (DAMPs) such as ATP. [6,12]. Purinergic receptor
stimulation leads to increased intracellular [Ca2+]i, potassium
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efflux from the cell, and subsequent generation of reactive oxygen
species [13–15].
To date most of the work in this area has utilized immune cells
such as macrophages as the working model of the NRLP3
inflammasome, demonstrating the classic model of priming,
followed by a second specific stimulus. The two stimuli usually
activate a TLR and a purinergic receptor of the P2X family,
usually P2X4 or P2X7 respectively. It remains unknown whether
this model is also true in other cell types. Interestingly, NLRP3 is
reported to be highly expressed in wet mucosal epithelial
membranes including the oropharynx, esophagus, ectocervix,
and urothelial layer of the bladder, but is not expressed in the
stomach, intestine, or lung. [16] However, research on the
activation and function of NLRP3 in these wet mucosal epithelia is
limited.
The wet mucosal membrane of the eye, the conjunctiva, is
exposed to the environment and at the same time highly sensitive
to the damaging effects of inflammation. The ocular surface
therefore requires a carefully balanced mechanism to initiate
inflammation only when absolutely necessary. While inflammation
is sometimes necessary to clear an invading pathogen, damaging
(chronic) inflammation is both the cause and consequence of most
ocular surface conditions including bacterial infections, Stevens-
Johnson syndrome, giant papillary conjunctivitis, seasonal allergic
conjunctivitis, neurotrophic keratitis, ocular mucous membrane
pemphigoid, and alkali and thermal burns. [17] Therefore, a need
exists to understand the pathways that regulate inflammation, to
provide a basis for the development of new, more targeted
therapies aimed at preventing the non-specific tissue damage
resulting from chronic inflammation.
Conjunctival goblet cells have been shown to be important in
defense against ocular surface infections via mucin secretion.
[18,19] In previous studies we found atypical bacteria on the
ocular surface of patients with overt inflammation [20] and
demonstrated that increased bacterial flora was associated with
reduced conjunctival goblet cell density, a marker of dry eye
syndrome and ocular surface inflammation. [17] We also found
altered levels of goblet cell mucin secretion in severe dry eye
patients. [21] It was therefore of interest to investigate the role of
goblet cells in regulating inflammation that can be induced by
bacteria.
The literature to date is limited in regard to the function of the
NLRP3 inflammasome in non-immune cells and to the best of our
knowledge, no published report exists on the expression and
function of inflammasomes in conjunctival epithelial cells. The
objectives of the present study were to: (1) determine whether
NLRP3 is expressed in the conjunctiva and (2) determine whether
goblet cells specifically contribute to innate mediated inflammation
via secretion of IL-1b. In the studies presented herein, we report
the constitutive expression of pro IL1-b and the constitutive
presence of all components of the NLRP3 inflammasome in the
conjunctival goblet cells. We also report the activation of the
NLRP3 inflammasome appears to be stimulated in conjunctival
goblet cell cultures by stimulation with the gram positive
bacterium S. aureus, which is commonly associated with ocular
surface infections [23,24] and is a specific activator of the NLRP3
inflammasome [15,17–19].
Materials and Methods
Animals
Male Sprague Dawley rats weighing between 125 g and 150 g
were obtained from Taconic Farms (Germantown, NY). Rats were
anesthetized with CO2 for 1 min, decapitated, and the bulbar and
fornical conjunctiva removed from both eyes. All experiments
were carried out in accordance the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and were
approved by the Schepens Eye Research Institute Animal Care
and Use Committee.
Human Material
The human eyes used for immunohistochemistry were obtained
from the San Diego Eyebank (San Diego, CA; www.sdeb.org).
Human conjunctival tissue was obtained from patients during
ocular surgery. The tissue, which would normally be discarded,
was obtained with written informed consent from each donor
using a protocol that adhered to the tenets of the Declaration of
Helsinki, and approved by the Schepens Eye Research Institute
and Massachusetts Eye and Ear Human Studies Internal Review
Boards. Three patients (two male and 1 female age range, 58–73)
underwent surgury for pars plana vitrectomy, pars plana
vitrectomy with membrane peeling, and scleral buckle. Conjunc-
tival tissue was also obtained from Heartland Lions Eye Bank
(Kansas City, MO; www.hleb.org).
Cell Culture
Goblet cells from rat and human conjunctiva were grown in
organ culture as described previously. [22–25] Pieces of minced
tissue were placed in RPMI 1640 medium supplemented with
10% fetal bovine serum (FBS), 2 mM glutamine (Lonza,
Walkersville, MD), and 100 mg/ml penicillin-streptomycin. The
tissue plug was removed after nodules of cells were observed. As
described previously [22–25], cells were identified as goblet cells
by the following characteristics: 1) morphology by light microscopy
both bright-field and following histochemical staining with
periodic acid–Schiff’s reagent (indicates secretory product); 2)
positive staining with the lectins Ulex europaeus agglutinin type I
(UEA-I), specific for rat, or Helix pomatia agglutinin (HPA) lectin,
specific for human; and antibodies to MUC5AC (all three stain
secretory product) and cytokeratin 7 (detects cell body); and 3)
negative staining with antibody to cytokeratin 4.
Immunohistochemistry
For immunofluorescence microscopy of intact conjunctiva, eyes
were enucleated with the lids intact and fixed in 4% formaldehyde
in phosphate buffered saline (PBS, 145 mM NaCl, 7.3 mM
Na2HPO4, and 2.7 mM NaH2PO4 (pH 7.2) overnight at 4uC.
Eyes were embedded in paraffin. Sections (6 mm) were placed on
slides and kept at 220uC until use. For immunohistochemistry,
human sections were deparaffinized and antigen retrieval was used
prior to staining for NLRP3. For immunohistochemistry of
cultured cells, primary cells were grown on glass coverslips and
then fixed in methanol before use for cytokeratin analysis and fixed
in 4% paraformaldehyde for all other protein analyses. The lectin
UEA-I conjugated to fluorescein isothiocyanate (FITC) (Sigma-
Aldrich, St. Louis, MO) was used at a dilution of 1:500; and the
lectin HPA conjugated to FITC (Pierce, Rockford, IL) was used at
a dilution of 1:1000. UEA-I binds to the goblet cell secretory
product carbohydrate a-L fucose on terminal sugars present on
mucins stored in secretory granules of goblet cells. HPA similarly
identifies L-galactosamine on terminal sugars of mucins. Antibod-
ies used were mouse anti-human NLRP3 (1:50, Enzo Life
Sciences, catalog number 804–819-C100) and rabbit anti-rat
caspase 1 (1:20) (Enzo Life Sciences, Plymouth, PA); rabbit anti-rat
ASC (1:50) (Santa Cruz Biotechnology, CA, USA); anti-rabbit
P2X4 and P2X7 (1:50) (Alomone Labs, Jerusalem, Israel); anti-
rabbit TLR2 (1:100) (Santa Cruz Biotechnology, CA). DAPI was
added to the mounting medium to identify cell nuclei. Secondary
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antibodies were conjugated to Cy3 (Jackson ImmunoResearch
Laboratories, West Grove, PA) and used at a dilution of 1:300.
Negative controls included use of the isotype controls for rabbit
(Santa Cruz Biotechnology) and mouse (Millipore, MA, USA)
antibodies.
Measurement of [Ca2+]i
Cultured goblet cells were seeded onto glass-bottom 35 mm
petri dishes (MatTek, Ashland, MA) and allowed to attach
overnight at 37uC. Cells were then incubated with 8 mM fura 2-
AM (Invitrogen, Carlsbad, CA) for 1 h at 37uC, in buffer
Figure 1. Human conjunctiva and rat conjunctiva constitutively express the NLRP3 inflammasome components. Human conjunctiva
was analyzed by immunohistochemistry and NLRP3 was shown to be highly expressed in the epithelium as indicated by pink staining (A). Arrows
indicate epithelial layer of conjunctiva; arrowheads indicate goblet cells. Isotype controls were negative. Rat conjunctiva was analyzed by
immunofluorescence microscopy (B) and all three of the inflammasome components NLRP3, caspase 1, and ASC were identified as demonstrated by
the red peri-nuclear staining. The green UEA staining indicates goblet cell secretory product, denoting the location of goblet cells in the conjunctiva.
Arrows indicate goblet cells. The mouse isotype controls (B) were negative as were the rabbit isotype controls (not shown). Epi, epithelium.
doi:10.1371/journal.pone.0074010.g001
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Figure 2. Constitutive expression of the NLRP3 inflammasome components in human and rat conjunctival goblet cells. Primary
cultures of human or rat goblet cells were analyzed by immunofluorescence microscopy after staining with antibodies against inflammasome
components NLRP3, caspase 1, and ASC (A). All three components were identified as indicated by the red peri-nuclear staining pattern. Rabbit
isotype controls (shown) and mouse isotype controls (not shown) were negative. The presence of NLRP3 (B), caspase 1 (C), ASC (D) and IL-1b (E) were
confirmed by western blot analysis in lysates from human goblet cells and rat conjunctiva and goblet cells. Please note that the positive controls for
NLRP3 and ASC are transfected cells lines overexpressing the protein and thus the amount of protein loaded for the western blots was below the
detection level of the b-actin antibody. In addition, the NLRP3 is tagged with His tag while the ASC is tagged with a FLAG tag causing these proteins
to run at a higher molecular weight than the native molecules.
doi:10.1371/journal.pone.0074010.g002
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(119 mM NaCl, 4.8 mM KCl, 1.0 mM CaCl2, 1.2 mM MgCl2,
1.2 mM KH2PO4, and 25 mM NaHCO3 supplemented with
10 mM HEPES, 5.5 mM glucose, 250 mM sulfinpyrazone, and
0.5% BSA) and then stimulated with ATP (0.1 mM–5 mM). In
separate experiments cells were pre-incubated with LTA (1 mg/ml
or 10 mg/ml) for 5 h, loaded with fura-2 for 1 h, and then
stimulated with ATP (5 mM). Fluorescent images of cells were
recorded and analyzed with a digital fluorescence imaging system
(InCyte Im2, Intracellular Imaging, Cincinnati, OH). Peak [Ca2+]i
was calculated by subtracting the basal values (before the addition
of agonist) from the peak calcium value.
Western Blotting Experiments
Pieces of rat conjunctiva or goblet cells cultured in 6 or 12 well
plates were lysed in RIPA buffer. The lysate was centrifuged at
10,0006g for 10 min at 4uC. Sample buffer (4X) was added to the
lysate, and proteins separated by SDS-PAGE through 10%
polyacrylamide, and transferred to nitrocellulose membrane to
be processed for Western blot. RIPA used for Western blotting
contained 10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1%
deoxycholic acid, 1% Triton X-100, 0.1% SDS, and 1 mM
EDTA. THP-1 cell lysate (Santa Cruz Biotechnology, Santa Cruz,
CA) was used as the positive control for detection of caspase-1,
ASC, and Pro-IL-1b [1,28–31]. Both untransfected HEK293 and
HEK293 cells transfected with NRLP3 were from Imgenex (San
Diego, CA).
Figure 3. Purinergic receptors P2X4, P2X7, and TLR2 are expressed in the rat conjunctiva and rat goblet cell cultures. All three
receptors were identified by red immunofluorescent staining. UEA stains goblet cell secretory products green, allowing the identification of goblet
cells within the conjunctiva. Rabbit isotype controls were negative. Arrows indicate location of goblet cells.
doi:10.1371/journal.pone.0074010.g003
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The primary antibodies used for Western blots with the
following dilutions: 1:200 for NLRP3 (R&D Systems, Minneapolis,
MN), 1:50 for ASC, and 1:1000 for caspase 1, (R&D Systems,
Minneapolis, MN) 1:100 for P2X4 and P2X7, 1:200 for TLR2
and 1:1000 for IL-1b (R&D Systems, Minneapolis, MN). Anti-
mouse secondary antibody conjugated to HRP was from Santa
Cruz (Santa Cruz, CA) and was used at a dilution of 1:2000.
Alternatively, anti-rabbit secondary antibody conjugated to HRP
(Millipore, Billerica, MA) was used at a dilution of 1:5000, anti-
sheep secondary antibody was from R&D Systems and used at a
dilution of 1:2500, and anti-goat secondary antibody (Santa Cruz
Biotechnology, Santa Cruz, CA) and was used at 1:5000.
Immunoreactive bands were visualized by the Enhanced Chemi-
luminescence method (Thermo Scientific, Rockford, IL).Figure 4. Purinergic receptors P2X4, P2X7 and TLR2 are
expressed in rat goblet cell cultures. All three receptors were
identified by western blot. Lanes 1–3 represent separate animals. B is
the positive control of rat brain. The b-actin blot is for both P2X4 and
P2X7 receptors blots.
doi:10.1371/journal.pone.0074010.g004
Figure 5. The purinergic receptors P2X4, P2X7, and TLR2 are functional in cultured rat goblet cells. Rat goblet cells were loaded with
fura-2 and then stimulated with ATP and intracellular calcium response measured. A typical trace from one experiment with ATP (5 mM, A) or
lipoteichoic acid (LTA, 10 mg/ml, B) is representative of 3 animals. Representative photographs of a single field of cells after treatment with ATP or
LTA, with warmer colors indicating intracellular Ca2+ increase, are shown as insets. Peak [Ca2+]i calculated for ATP (0.1 mM–5 mM) from 3 experiments,
is shown in C. Peak [Ca2+]i for goblet cells, also preincubated with LTA for 5 h and then loaded with fura-2 for 1 additional h before addition of ATP
(5 mM), calculated from 3 experiments, is shown in D. Results are expressed as mean 6 SEM. * indicates significance of p,0.05 from no addition (0).
doi:10.1371/journal.pone.0074010.g005
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S. aureus (RN6390) Culture and Challenge of Rat
Conjunctival Goblet Cells
S. aureus (RN6390) was cultured as previously described. [26]
Briefly S. aureus was cultured at 37uC overnight with continuous
agitation. This pre-culture was then diluted and grown at 37uC to
an OD595 nm of 0.5 (early log phase). After centrifugation at
5006g for 10 min, the supernatant was discarded and bacteria
resuspended in RPMI-1640 medium with 1% FBS. Rat conjunc-
tival goblet cells were seeded in 12 well culture plates (500 cells per
well) in medium without antibiotics 24 h prior to infection, and
some cultures were preincubated with the caspase 1 inhibitor Z-
YVAD (10 mM) for 30 min prior to infection with S. aureus
(Biovision, California). S. aureus were added at a multiplicity of
infection (MOI) of 20, 40 or 60, and incubated for 6 h at 37uC in
5% CO2. Cultures were then treated for an additional 2 h with
5 mM ATP or no additions. At 8 h cell culture supernatant was
collected for analysis of IL-1b by ELISA (R&D Systems) that was
performed according to the manufacturer’s instructions. The
ELISA detected IL-1b over a range of 1 pg/ml –2500 pg/ml. In
parallel, cells were lysed in RIPA buffer and protein collected for
analysis by western blot. Cell viability assays using 0.05% (w/v)
trypan blue (Sigma-Aldrich, St. Louis, MO) were performed in
preliminary experiments to ascertain optimum time points to
examine infection.
FLICA Assay for Active Caspase 1 Analysis
Active caspase 1 was detected using a fluorescent inhibitor of
caspases (FLICA, Immunochemistry Technologies, Bloomington,
MN, USA), according to the manufacturer’s instructions. Cells
were cultured, with or without S. aureus with or withoutATP as
previously described and 10 ml of a 306FLICA solution were
added. The culture plates were covered with aluminium foil and
incubated 1 h at 37uC in 5% CO2. Following incubation, the cells
were washed with 2 ml of wash buffer, and then stained with
Hoechst 33342 stain (0.5% v/v) according to manufacturer’s
instructions. Stained cells were viewed on an inverted phase
contrast microscope equipped for epifluorescence (Eclipse TE 300,
Nikon, Tokyo, Japan; UV filter with excitation 490 nm, emission
.520 nm for green fluorescence of caspase 1 positive cells, and
excitation 365 nm, emission 480 nm for visualization of blue
fluorescence from nuclear staining by Hoechst stain). The total
number of nuclei in four (40X) fields of view was counted, and the
number of cells staining green (indicative of active caspase 1) was
expressed as a percentage of the total.
Statistical Analysis
All results are representative of three independent experiments.
Western blot results were expressed as the fold-increase above
basal. Results are presented as mean6SEM. Data were analyzed
by Student t test. A p value,0.05 was considered statistically
significant.
Results
The NLRP3 Inflammasome Components NLRP3, ASC and
Caspase 1 are Constitutively Present in the Human and
Rat Conjunctiva
Unlike NLRP1 that is located in the nuclei, NLRP3 is usually
found in the cytoplasm. [16] Immunohistochemical analysis
identified the NLRP3 protein in the human conjunctiva
(Figure 1A). The lower power micrographs demonstrate the
NLRP3 immunoreactivity is present in the conjunctiva but
terminates at the end of the limbus adjacent to the peripheral
cornea. NLRP3 was identified in the cytoplasm of both goblet and
stratified squamous cells. The higher power micrographs indicate
that NRLP3 immunoreactivity is present throughout the cell layers
of the conjunctival epithelium and in both goblet and stratified
squamous cells. The isotype negative control had no visible
staining.
In rat conjunctival sections goblet cells were identified by UEA-
1 binding that indicates the position of the secretory granules with
the goblet cell body subjacent to this staining (Figure 1B, first panel
on left). In the absence of UEA-1, goblet cell secretory granules
and hence goblet cell bodies can be identified by the large black
holes in the epithelium (Figure 1B second through fourth panels
from left). The presence of NLRP3 inflammasome components
NLRP3, ASC and caspase 1 were investigated in rat conjunctival
sections. All three inflammasome components were identified in
the cytoplasm of both goblet and stratified squamous cells
(Figure 1B). The inflammasome components were strongly
expressed throughout the epithelium of the conjunctiva, but were
not detected in the stroma. NRLP3 was found diffusely throughout
the cytoplasm of goblet and stratified squamous cells.
The NLRP3 Inflammasome Components (NLRP3, ASC,
Caspase 1) and pro IL-1b are Constitutively Present in
Human and Rat Conjunctival Goblet Cells
Primary cultures of human and rat conjunctival goblet cells
were characterized using the goblet cell specific markers
MUC5AC, HPA and cytokeratin 7 as described previously.
[23,24,27] These cultures were negative for the stratified
squamous epithelial cell marker cytokeratin 4 (data not shown).
All NLRP3 inflammasome components NLRP3, ASC and caspase
1 were detected by immunofluorescence microscopy in both
human and rat goblet cell cultures (Figure 2A), with each
demonstrating a cytoplasmic staining pattern. The isotype
negative control had no visible staining.
Western blotting analysis was performed on homogenates
prepared from rat conjunctival tissue, cultured rat and human
conjunctival goblet cells, transfected HEK293 cells as the positive
control and untransfected HEK293 cells as the negative control.
NRLP3 protein was present as a 118 kDa protein in all the
conjunctival samples and the positive control, but not in the
Figure 6. Effect of S. aureus on Goblet Cell Viability. Cultured rat
goblet cells were incubated with S. aureus at MOIs of 20, 40, and 60 for
0–24 h, and cell viability was determined by trypan pan blue exclusion.
Data is mean 6 SEM from 3 independent experiments.
doi:10.1371/journal.pone.0074010.g006
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negative control (Figure 2B). Please note that the positive control
for NLRP3 is a transfected cell line overexpressing NLRP3 flagged
with a His tag which runs at a higher molecular weight than native
NLRP3.
Caspase 1 consists of several isoforms. Caspase 1a is a 50 kDa
protein while caspase 1b, d and c have molecular weights from
30–45 kDa. Active capase 1 is a 20 kDa protein. In rat
conjunctiva, caspase 1 was present as bands at 50, 45, and
20 kDa (Figure 2C) indicating the presence of several isoforms of
caspase 1 as well as active caspase 1. In rat goblet cells caspase 1
was seen at 50 and 20 kDa indicating the presence of caspase 1a
and active caspase 1. In the positive control THP1 cells, caspase 1
was detected as bands at the 50, 45, and 20 kDa level indicating
the presence of caspase 1 and several additional isoforms along
with active caspase 1 [1,28]. In human goblet cells caspase 1 was
detected as a large band at 45 kDa and a band at 20 kDa
indicating the presence of one or more isoforms of caspase 1.
ASC is a 24 kDa protein. A band at this molecular weight was
detected in THP-1 cells as well as rat conjunctiva, rat and human
goblet cells (Figure 2D) [29]. An additional positive control used
for ASC was ASC protein tagged with FLAG that ran at a higher
molecular weight (30 kDa) than native ASC. This control protein
was detected at the expected molecular weight.
Pro IL-1b exists as a 31 kDa protein that is cleaved by caspase 1
to produce mature or active IL1b that has a molecular weight of
17 kDa and is secreted. A band at 31 kDa was detected in the
positive control THP-1 cells, rat conjunctiva and goblet cells, and
human goblet cells (Figure 2E) [30,31]. No band was detected at
17 kDa in any of the samples.
Figure 7. Effect of S. aureus on NLRP3 and ASC expression by cultured rat goblet cells. Cultured rat goblet cells were incubated with S.
aureus (MOI 20 or 60) for 6 h. Cultures were treated for an additional 2 h with ATP (5 mM) or buffer alone. Cell lysates collected and analysed by
western blot. Representative blots are shown in A and C. Lower, major band in ASC blot was scanned. Blots were scanned and quantified. Data from
a single experiment, representative of two experiments, is shown in B and means6 SEM from 3 independent experiments are shown in D. * indicates
significance of p,0.05 compared to no addition which was set to 1.
doi:10.1371/journal.pone.0074010.g007
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The Purinergic Receptors P2X4 and P2X7 and the
Bacterial Receptor TLR2 are Present in Rat Conjunctival
Goblet Cells
The ionotropic purinergic receptors P2X4 and P2X7 are
involved in inflammasome activation via binding of extracellular
ATP, [12,13] and TLR2 is critical in the priming of the
inflammasome and activated by lipotechoic acid (LTA) a
component of the gram positive S. aureus cell wall [32] or by S.
aureus binding. [10] All three receptors are present in both goblet
and stratified squamous cells of the rat conjunctiva with limited
expression in the stroma (Figure 3top). In the conjunctiva P2X4 is
located on the membranes surrounding the goblet and stratified
squamous cells. In cultured goblet cells P2X4 immunoreactivity is
detected on the plasma membranes and contractile stress fibers
located within the cytoplasm. P2X7 immunoreactivty in the
conjunctiva demonstrated intense staining in the cell bodies of the
goblet cells with diffuse staining in the cytoplasm of the stratified
squamous cells (Figure 3 top). In cultured goblet cells the P2X7
positivity was located diffusely in the cytoplasm. TLR2 was
localized in goblet cell bodies and in stratified squamous cells
(Figure 3 bottom). TLR2 immunoreactivity was present in the
cytoplasm and plasma membranes in cultured goblet cells.
The presence of P2X4, P2X7, and TLR2 was determined by
western blotting analysis in rat conjunctival goblet cell homoge-
nate from three different animals (Figure 4). Rat brain homoge-
nate was used as a positive control. P2X4 was detected at its
expected 50 kDa protein and the same molecular weight as the
positive control of rat brain, P2X7 at 75 kDa and the same
molecular weight as the positive control of rat brain, and TLR2 at
95 kDa. We also identified TLR 1, 4 and 6, and cluster of
differentiation 14 (CD14) on rat goblet cells (data not shown).
Measurement of [Ca2+]i was used to determine if the purinergic
receptors (P2X4 and P2X7) were functional in rat goblet cells.
Primary cultures of rat goblet cells were loaded with fura-2 and
stimulated with ATP (1027–561023 M) a non-specific activator of
P2X receptors. ATP increased [Ca2+]i in the goblet cells with a
Figure 8. Effect of S. aureus on Caspase 1 and proIL-1b protein expression. Cultured rat goblet cells were incubated with S. aureus (MOI 20 or
60) for 6 h. Cultures were treated for an additional 2 h with ATP (5 mM) or buffer alone. Cell lysates were collected and analyzed by western blot.
Representative blots are shown in A and C. Blots were scanned and mean6 SEM from 3 independent experiments are shown in B and D. * indicates
significance of p,0.05 compared to no addition which was set to 1.
doi:10.1371/journal.pone.0074010.g008
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rapid peak response that declined back to basal levels. ATP
elevated [Ca2+]i in a concentration dependent manner, with ATP
from 1025–561023 M increasing [Ca2+]i to significantly higher
levels than in control (unstimulated) cells (Figure 5A and C). The
highest peak increase over basal was 257.0636.9 nM.
Rat goblet cells were also stimulated with LTA a potent
activator of TLR2. [32] Stimulation with LTA (1 mg/ml or 10 mg/
ml) resulted in intracellular Ca2+ responses that were significantly
higher than control (unstimulated) goblet cells (Figures 5B and D).
The average peak Ca2+ response of rat goblet cells to LTA (1 mg/
ml) was 93 nM as compared to 204.760.3 nM for ATP
(561023 M) (Figure 5D). To mimic the two stimulus hypothesis
of activation of the NRLP3 inflammasome, goblet cell cultures
were pre-incubated with LTA (1 mg/ml or 10 mg/ml) for 5 h prior
to loading with fura-2 for 1 additional hour, and then stimulated
with ATP (561023 M). Preincubation with LTA did not alter the
intracellular Ca2+ response to ATP which was 251.0660.6 nM
and 201.0650.0 nM for 1 mg/ml and 10 mg/ml respectively
compared to ATP alone that was 204.760.3 nM (Figure 5D).
These experiments show that the purinergic receptors P2X4
and P2X7 and TLR2 are present and functional in rat goblet cells.
They also demonstrate that bacterial LTA treatment does not alter
the purinergic intracellular Ca2+ response.
S. aureus Challenge with or without ATP Increases NLRP3,
ASC, Caspase 1 and Pro IL-1b Protein Expression in Rat
Conjunctival Goblet Cells
Rat goblet cell cultures were challenged with S. aureus (RN6390)
at MOI 20, 40 or 60 over 24 h and cell viability determined using
the trypan blue exclusion assay. These MOIs were chosen as they
were shown to be effective in stimulating IL-1 b expression in
human corneal epithelial cells in a previous study. [26] Over 80%
of the cells remained viable at each MOI at 8 h before a rapid
decline in cell viability (Figure 6). Therefore 8 h was chosen as the
end point for subsequent experiments.
Figure 9. Active caspase 1 expression in rat goblet cells treated with S. aureus and ATP. Primary cultures of rat goblet cells were incubated
with S. aureus (MOI 20 or 60) for 6 h. Cultures were treated for an additional 2 h with ATP (5 mM) or buffer alone. The FLICA reagent, which detects
only active caspase 1, was added followed by the nuclear Hoescht stain and viewed by immunofluorescence microscopy. Representative micrographs
are shown in A. The total number of nuclei in four fields of view and the number of cells with staining green (indicative of active caspase 1) were
counted. Data is expressed as mean6 SEM from 3 independent experiments, and are shown in B. * indicates significance of p,0.05 compared to no
addition, which was set to 1. Magnification 406.
doi:10.1371/journal.pone.0074010.g009
Activation of NLRP3 Inflammasomes in Conjunctiva
PLOS ONE | www.plosone.org 10 September 2013 | Volume 8 | Issue 9 | e74010
Cultured rat conjunctival goblet cells were incubated with S.
aureus for 6 hr with or without ATP (561023 M) for an additional
2 hr, cells homogenized and analysed for amount of NRLP3 and
ASC. Incubation with S. aureus alone at 20 and 60 MOI increased
the amount of NRLP3 over basal to 1.3 and 2.0 fold respectively
(Figure 7A and B). Addition of ATP slightly increased the response
to S. aureus and ATP added alone also increased the amount of
NRLP3.
For ASC, S. aureus at 20 and 60 MOI significantly increased the
amount of ASC compared to basal (Figure 7C and D). Addition of
ATP did not further increase the amount of ASC at either
concentration of bacteria. ATP alone did not alter the amount of
ASC.
Results similar to those found with ASC were obtained for
caspase 1 and pro IL-1b (Figure 8A, B, C and D). Goblet cells
challenged with S. aureus, with or without ATP, also significantly
increased caspase 1 and pro IL-1b protein expression as compared
to basal levels. The level of caspase 1 and pro IL-1b protein
expression was not significantly different between cells challenged
only with S. aureus and S. aureus challenged with ATP.
Taken together these results suggest that S. aureus itself without
addition of ATP can increase the amount of the constituents of the
NRLP3 inflammasome including NLRP3, ASC, and caspase 1. In
addition S. aureus increases the amount of pro IL-1b. ATP alone
does not increase the level of ASC, caspase 1or pro IL-1b.
S. aureus Challenge, with or without ATP, Leads to IL-1b
Secretion from Rat Conjunctival Goblet Cells Dependent
on Caspase 1 Activation
The active form of caspase 1 was detected in primary cultures of
rat goblet cells challenged with S. aureus, with or without ATP
(561023 M), as determined by the FLICA assay (Figure 9A). S.
aureus challenge alone, ATP treatment alone, or the combination
of S. aureus with ATP treatment, resulted in significant activation of
caspase 1 as compared to untreated cells. The greatest amount of
caspase 1 activation was observed in cultures that were treated
with the highest MOI of S. aureus (MOI 60 (21%)), and this
activation was enhanced when ATP was added to the cultures
(36%) (Figure 9B). It is important to note that there was no
significant difference in cell viability between MOI 20 and MOI
60 (Figure 6).
IL-1b secretion was measured by ELISA in the supernatant
isolated from cultured rat conjunctival goblet cells stimulated by S.
aureus at 20 and 60 MOI with or without ATP (561023 M) or
ATP alone. Challenge of rat goblet cells with S. aureus, with or
without ATP, resulted in a significant increase in IL-1b secretion
as compared to untreated cells (Figure 10). Cells challenged with S.
aureus at an MOI 60 resulted in significantly more IL-1b secretion
than from cells challenged with S. aureus at MOI 20 (40 pg/ml and
24 pg/ml respectively). IL-1b secretion from goblet cells was
slightly increased when ATP was added to S. aureus stimulated
goblet cell cultures, compared to S. aureus alone (34 pg/ml for S.
aureus MOI 20 plus ATP compared to 24 pg/ml for S. aureus MOI
20 alone; and 55 pg/ml for S. aureus MOI 60 plus ATP compared
to 40 pg/ml for S. aureus MOI 60 alone). Interestingly, IL-1b
secretion from goblet cells treated with ATP alone was not
significantly different from untreated cells (Figure 10), even in the
presence of significantly elevated caspase 1 activity (Figure 9).
Taken together, these data demonstrate the importance of a
priming agent for the induction of pro IL-1b. In the absence of S.
aureus, goblet cells treated with ATP alone fail to upregulate pro
IL-1b. Therefore, even with the activation of caspase 1, there is a
limited store of pro IL-1b to convert to mature IL-1b in the
absence of a priming agent such as S. aureus.
The role of caspase 1 was confirmed using the caspase 1
inhibitor Z-YVAD. The addition of Z-YVAD to the rat goblet cell
cultures challenged with S. aureus, with or without ATP, resulted in
a significant decrease in IL-1b secretion with IL-1b secretion
dropping from 54 pg/ml (no inhibitor present) to 12 pg/ml
(inhibitor present) for cultures incubated with S. aureus MOI 60
and ATP (Figure 10). No significant difference was noted in IL-1b
secretion between cells treated with ATP alone, and cells treated
with ATP and the caspase 1 inhibitor Z-YVAD. These results
provide evidence that S. aureus activates the secretion of IL-1b via
the caspase 1 pathway.
Discussion
We found that the NLRP3 inflammasome is present in rat
conjunctival goblet cells and can be activated by S. aureus. The
NLRP3 inflammasome appears to contribute to inflammation in
the conjunctiva by activating the secretion of IL-1b via the caspase
1 pathway. NLRP3 was previously reported to be highly expressed
in wet mucosal epithelium within the cytoplasm of cells. [16]
Kummer and colleagues [14] speculated that the expression of
NLRP3 in such sites allows rapid sensing of invading pathogens or
other danger signals, thereby triggering an innate immune
response. The ocular surface is exposed to the environment, yet
to maintain visual clarity, it is required to balance inflammation
with immune privilege. Previous work demonstrated that mouse
eyes express high levels of NLRP3 mRNA compared to other body
tissues. [33] An additional study also reported NLRP3 mRNA
expression in the whole eyes of mice challenged with LPS, but not
in unchallenged eyes [34]. Benko et al previously reported NLRP3
mRNA was detected in human corneal epithelial cells, but was not
detected at the protein level. [35] Our results show that NLRP3
protein, as well as the other constituent components of the NLRP3
inflammasome, are highly expressed in the goblet cells of the
conjunctival epithelium.
In addition to the constitutive expression of NLRP3, we found
that TLR2 is also expressed on the surface of rat goblet cells in
Figure 10. Effect of Inhibition of Caspase 1 on IL-1b secretion in
response to S. aureus and ATP. Primary cultures of rat goblet cells
were treated with or without the caspase 1 inhibitor Z-YVAD for 1 h and
then incubated with S. aureus (MOI 20 or 60) for 6 h. Cultures were
treated for an additional 2 h with ATP (5 mM) or buffer alone. Culture
supernatant was removed and analyzed for IL-1b by ELISA. Data is
expressed as mean6 SEM from 3 independent experiments. * indicates
significance of p,0.05 compared to no addition. # indicates
significance of p,0.05 compared to no inhibitor.
doi:10.1371/journal.pone.0074010.g010
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culture, as were the purinergic receptors P2X4 and P2X7.
Purinergic receptors are known to be activated by signals such
as ATP, and TLRs by bacterial cell wall components, such as
LTA. Both S. aureus and ATP are potent activators of the NLRP3
inflammasome, and we showed that ATP or LTA stimulation of
goblet cells increases [Ca2+]i. Thus TLR2, P2X4, and P2X7 are
indeed functional in goblet cell cultures, and could play a role in
the priming and activation of the NLRP3 inflammasome. It was
previously thought that caspase 1 regulation in macrophages
required inflammatory stimuli that signalled through the TLRs to
up-regulate gene products required for activation of the caspase 1
processing machinery and a second stimulus (such as ATP) to
activate the inflammasome [36]. However, later work demon-
strated that caspase 1 activation may be independent of TLRs.
One study in particular demonstrated that pannexin-1 (a
hemichannel protein that interacts with the P2X7 receptor)
activation promotes cytosolic recognition of bacterial products to
activate the NLRP3 inflammasome, which proceeds independent
of TLR signalling. [37]. Our data demonstrate that ATP alone
upregulates the expression NLRP3 in this inflammasome (Fig-
ures7) and activates caspase-1 (Figure 9), suggesting inflammasome
activation. However, in the absence of a priming agent, there is a
limited store of pro IL-1b to convert to mature IL-1b. Interestingly
though, we demonstrate that goblet cells treated with S. aureus do
not require ATP for inflammasome activation. In fact, S. aureus can
act as both a priming agent, to upregulate pro IL-1b (Figure 8) and
an activating agent to activate the inflammasome (Figure 9). The
exact mechanism of NLRP3 inflammasome activation has not
been fully elucidated in this study and requires further work with
regards to TLR and P2X receptor involvement.
In this present study S. aureus challenge of rat goblet cells led to
the activation of the NLRP3 inflammasome, demonstrated by the
activation of caspase 1 and the secretion of IL-1b into the culture
supernatants. We found that ATP, in combination with S. aureus,
significantly enhanced IL-1b secretion compared to S. aureus alone,
but this only reached significance in cultures treated with the
higher MOI (MOI 60). This may be due to the amount of the pro
form of IL-1b that is processed by the cell and made available for
secretion, such that higher MOIs of S. aureus would result in more
pro IL-1b being processed. Western blots revealed that pro IL-1b
is present in rat goblet cells constitutively, which suggests that a
small reserve is present and ready to become activated and
released upon encounter with a danger trigger or pathogen. When
the goblet cell cultures were stimulated with ATP alone, a small
amount of IL-1b was secreted from the cultures into the
supernatant, but this response failed to reach statistical significance
when compared to untreated cells. Again this low response is most
likely due to the limited amount of pro IL-1b available for
processing and illustrates the importance of the priming agent.
Bauernfeind et al [38] reported that NFkB activation was required
for expression of pro IL-1b and NLRP3 protein and that the
activation of the NLRP3 inflammasome was dependent on the
level of NLRP3 expression. They found that the NLRP3
inflammasome was only activated in mouse macrophages that
were first primed with a TLR agonist to activate the NFkB
pathway, leading to the expression of NLRP3 and subsequent
activation of the inflammasome via a NLRP3 agonist such as ATP.
Our results provide evidence that although the inflammasome
components are synthesized and pro IL-1b is constitutively present
in the conjunctiva, IL-1b is not secreted until the activation step
occurs. It is reported that in hematopoietic cells two signals are
needed to activate the NLRP3 inflammasome and induce IL-1b
secretion. These signals are: 1) a TLR2 agonist such as LTA from S.
aureus to activate the NFkB pathway, which leads to enhanced
expression of pro IL-1b and NLRP3; and 2) a NLRP3 inflammasome
agonist such as a toxin (e.g. S. aureus alpha toxin, (the RN6390 strain
used in this study produces alpha toxin)) or a danger signal (e.g.
ATP). Our study shows that S. aureus increases the synthesis of pro
IL-1b and also increases the secretion of IL-1b. Taken together,
our data suggests that bacterial cell wall components, such as LTA,
increases the expression of pro IL-1b while bacterial toxins, which
have been previously shown to activate the inflammasome [6,8,10]
may be responsible for the activation the NLRP3 inflammasome
and secretion of active IL-1b in rat goblet cells.
The specific mechanism of NLRP3 inflammasome activation is
currently under study. Several stimuli are known to activate the
inflammasome and it is not clear as yet if all stimuli use the same
method of activation. Tschopp and colleagues [1] were the first to
coin the term inflammasome, and later showed that it could be
activated by bacterial muramyl dipeptide. Further research has
demonstrated the activation of the NLRP3 inflammasome in
response to bacteria such as S. aureus. [6,8–10] Recent literature
suggests that TLR agonists such as LTA first activate transcription
of IL-1b via the NFkB pathway; however processing of IL-1b to
the active form appears to be initiated by S. aureus toxins, such as
alpha toxin, which activates the inflammasome through an
unknown mechanism. [6,8,10] Our study is consistent with these
findings. We demonstrated that S. aureus leads to an increase in pro
IL-1b protein expression and also to an increase in the expression
of the NLRP3 inflammasome proteins. The S. aureus RN6390
strain used, which is known to produce toxins [26], also activated
the caspase 1 pathway leading to IL-1b secretion from the
cultures. Blocking of the caspase 1 pathway resulted in reduced
secretion of IL-1b. Thus, in conjunctival goblet cells, S. aureus is
sufficient to upregulate the expression of IL-1b and activate the
NLRP3 inflammasome resulting in the secretion of active IL-1b.
Our data indicate that the NLRP3 inflammasome plays a role
in initiating/promoting inflammation in the conjunctiva by
activating IL-1b. The molecular mechanisms of how NLRP3
recognizes activators of the inflammasome in the conjunctiva
remain to be elucidated, as does the sequence of events leading to
ocular surface inflammation via the NLRP3 inflammasome. The
inflammasome has been associated with specialized forms of cell
death, pyronecrosis [39] (caspase 1 independent) and pyroptosis,
[40] which may occur in cases of exacerbated inflammation.
Ocular surface inflammation is associated with a reduced goblet
cell density. [18,19] We therefore hypothesize that normally the
NLRP3 inflammasome is constitutively expressed for pathogen/
danger surveillance, and activates an inflammatory response when
triggered in order to protect the host tissue and eradicate the
pathogen. However, the NLRP3 inflammasome may also play a
pathophysiological role in chronic inflammatory states by inducing
cell death when the acute inflammatory response fails. In the
conjunctiva, subsequent goblet cell death may lead to lack of
mucin on the ocular surface, which can enhance inflammation.
[17].
We conclude that the components of the NLRP3 inflammasome
are constitutively expressed in the conjunctival goblet cells.
Moreover, exposure to a strain of S. aureus that is known to
produce toxins associated with activation of the NLRP3 inflam-
masome, triggers the activation of caspase-1 and secretion of
mature IL-1b, further supporting a S. aureus-mediated activation of
the NLRP3 inflammasome in goblet cells. Additional studies with
NLRP3 siRNA will confirm whether or not S. aureus-mediated
activation of caspase-1 and secretion of mature IL-1b is solely
dependent upon the NLRP3 inflammasome pathway. With
further research into the exact mechanisms of activation, including
clarification of the potential roles of the TLRs and P2X receptors,
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the NLRP3 inflammasome may prove to be a valuable target in
development of new and more specific therapies for ocular surface
inflammation.
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